Structured evidence table for Quercetin Seasonal Allergy Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Quercetin Seasonal Allergy Randomized Trial | Current therapies mainly alleviate symptoms without addressing underlying immune dysfunction, which has increased interest in nutritional bioactive compounds as preventive or modulatory agents. | 3 | Zafrilla P (2025) | Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review. |
| Quercetin Seasonal Allergy Randomized Trial | This review summarizes evidence on omega-3 polyunsaturated fatty acids, vitamin D, curcumin, ginger bioactives, quercetin, and epigallocatechin gallate (EGCG) in allergy prevention and management. | 3 | Zafrilla P (2025) | Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review. |
| Quercetin Seasonal Allergy Randomized Trial | Ginger constituents ([6]-gingerol, [6]-shogaol) modulate Th1/Th2 balance, mast-cell activity, and oxidative stress, with early clinical evidence in rhinitis and asthma. | 3 | Zafrilla P (2025) | Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review. |
| Quercetin Seasonal Allergy Randomized Trial | Background/Objectives: Allergic diseases are highly prevalent worldwide and represent a significant public health burden. | 3 | Zafrilla P (2025) | Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review. |
| Quercetin Seasonal Allergy Randomized Trial | The primary pathogenic mechanism of Type I hypersensitivity reactions involves histamine-mediated activation of the H1 receptor (H1R) and the subsequent signaling of the phospholipase C β-inositol trisphosphate (PLCβ-IP 3 ) pathway. | 4 | Frati F (2026) | Preclinical In Vitro Evaluation of an Innovative Nutraceutical Mixture Modulating the Histamine H1 Receptor-Preliminary Data. |
| Quercetin Seasonal Allergy Randomized Trial | The present study evaluates the in vitro efficacy of a novel nutraceutical mixture-Quercetin, Perilla frutescens , Boswellia serrata , Blackcurrant, Parthenium , Helichrysum , Lactobacillus Acidophilus ( L. | 4 | Frati F (2026) | Preclinical In Vitro Evaluation of an Innovative Nutraceutical Mixture Modulating the Histamine H1 Receptor-Preliminary Data. |
Source documents